Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking
Background: Although advance has been made in understanding the pathogenesis of mature T-cell neoplasms, the initiation and progression of angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), remain poorly understood. A subset of AITL/PTCL-NOS...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
eLife Sciences Publications Ltd
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a27d55bdfc5a40f69b987bae0c445bcb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a27d55bdfc5a40f69b987bae0c445bcb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a27d55bdfc5a40f69b987bae0c445bcb2021-11-15T06:43:36ZMutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking10.7554/eLife.663952050-084Xe66395https://doaj.org/article/a27d55bdfc5a40f69b987bae0c445bcb2021-09-01T00:00:00Zhttps://elifesciences.org/articles/66395https://doaj.org/toc/2050-084XBackground: Although advance has been made in understanding the pathogenesis of mature T-cell neoplasms, the initiation and progression of angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), remain poorly understood. A subset of AITL/PTCL-NOS patients develop concomitant hematologic neoplasms (CHN), and a biomarker to predict this risk is lacking. Methods: We generated and analyzed the mutation profiles through 537-gene targeted sequencing of the primary tumors and matched bone marrow/peripheral blood samples in 25 patients with AITL and two with PTCL-NOS. Results: Clonal hematopoiesis (CH)-associated genomic alterations, found in 70.4% of the AITL/PTCL-NOS patients, were shared among CH and T-cell lymphoma, as well as concomitant myeloid neoplasms or diffuse large B-cell lymphoma (DLBCL) that developed before or after AITL. Aberrant AID/APOBEC activity-associated and tobacco smoking-associated mutational signatures were respectively enriched in the early CH-associated mutations and late non-CH-associated mutations during AITL/PTCL-NOS development. Moreover, analysis showed that the presence of CH harboring ≥2 pathogenic TET2 variants with ≥15% of allele burden conferred higher risk for CHN (p=0.0006, hazard ratio = 14.01, positive predictive value = 88.9%, negative predictive value = 92.1%). Conclusions: We provided genetic evidence that AITL/PTCL-NOS, CH, and CHN can frequently arise from common mutated hematopoietic precursor clones. Our data also suggests smoking exposure as a potential risk factor for AITL/PTCL-NOS progression. These findings provide insights into the cell origin and etiology of AITL and PTCL-NOS and provide a novel stratification biomarker for CHN risk in AITL patients. Funding: R01 grant (CA194547) from the National Cancer Institute to WT.Shuhua ChengWei ZhangGiorgio InghiramiWayne TameLife Sciences Publications Ltdarticleangioimmunoblastic t cell lymphomaclonal hematopoiesisconcurrent hematologic neoplasmmutated hematopoietic precursorsmokingbiomarkerMedicineRScienceQBiology (General)QH301-705.5ENeLife, Vol 10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
angioimmunoblastic t cell lymphoma clonal hematopoiesis concurrent hematologic neoplasm mutated hematopoietic precursor smoking biomarker Medicine R Science Q Biology (General) QH301-705.5 |
spellingShingle |
angioimmunoblastic t cell lymphoma clonal hematopoiesis concurrent hematologic neoplasm mutated hematopoietic precursor smoking biomarker Medicine R Science Q Biology (General) QH301-705.5 Shuhua Cheng Wei Zhang Giorgio Inghirami Wayne Tam Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking |
description |
Background: Although advance has been made in understanding the pathogenesis of mature T-cell neoplasms, the initiation and progression of angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), remain poorly understood. A subset of AITL/PTCL-NOS patients develop concomitant hematologic neoplasms (CHN), and a biomarker to predict this risk is lacking.
Methods: We generated and analyzed the mutation profiles through 537-gene targeted sequencing of the primary tumors and matched bone marrow/peripheral blood samples in 25 patients with AITL and two with PTCL-NOS.
Results: Clonal hematopoiesis (CH)-associated genomic alterations, found in 70.4% of the AITL/PTCL-NOS patients, were shared among CH and T-cell lymphoma, as well as concomitant myeloid neoplasms or diffuse large B-cell lymphoma (DLBCL) that developed before or after AITL. Aberrant AID/APOBEC activity-associated and tobacco smoking-associated mutational signatures were respectively enriched in the early CH-associated mutations and late non-CH-associated mutations during AITL/PTCL-NOS development. Moreover, analysis showed that the presence of CH harboring ≥2 pathogenic TET2 variants with ≥15% of allele burden conferred higher risk for CHN (p=0.0006, hazard ratio = 14.01, positive predictive value = 88.9%, negative predictive value = 92.1%).
Conclusions: We provided genetic evidence that AITL/PTCL-NOS, CH, and CHN can frequently arise from common mutated hematopoietic precursor clones. Our data also suggests smoking exposure as a potential risk factor for AITL/PTCL-NOS progression. These findings provide insights into the cell origin and etiology of AITL and PTCL-NOS and provide a novel stratification biomarker for CHN risk in AITL patients.
Funding: R01 grant (CA194547) from the National Cancer Institute to WT. |
format |
article |
author |
Shuhua Cheng Wei Zhang Giorgio Inghirami Wayne Tam |
author_facet |
Shuhua Cheng Wei Zhang Giorgio Inghirami Wayne Tam |
author_sort |
Shuhua Cheng |
title |
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking |
title_short |
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking |
title_full |
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking |
title_fullStr |
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking |
title_full_unstemmed |
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking |
title_sort |
mutation analysis links angioimmunoblastic t-cell lymphoma to clonal hematopoiesis and smoking |
publisher |
eLife Sciences Publications Ltd |
publishDate |
2021 |
url |
https://doaj.org/article/a27d55bdfc5a40f69b987bae0c445bcb |
work_keys_str_mv |
AT shuhuacheng mutationanalysislinksangioimmunoblastictcelllymphomatoclonalhematopoiesisandsmoking AT weizhang mutationanalysislinksangioimmunoblastictcelllymphomatoclonalhematopoiesisandsmoking AT giorgioinghirami mutationanalysislinksangioimmunoblastictcelllymphomatoclonalhematopoiesisandsmoking AT waynetam mutationanalysislinksangioimmunoblastictcelllymphomatoclonalhematopoiesisandsmoking |
_version_ |
1718428572370075648 |